Singapore markets closed

AstraZeneca PLC (AZN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
79.24+1.30 (+1.67%)
At close: 04:00PM EDT
79.19 -0.05 (-0.06%)
After hours: 06:45PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 245.59B
Enterprise value 272.12B
Trailing P/E 39.13
Forward P/E 18.73
PEG ratio (5-yr expected) 0.98
Price/sales (ttm)5.20
Price/book (mrq)6.56
Enterprise value/revenue 5.72
Enterprise value/EBITDA 19.77

Trading information

Stock price history

Beta (5Y monthly) 0.15
52-week change 318.18%
S&P500 52-week change 324.16%
52-week high 380.86
52-week low 360.47
50-day moving average 378.06
200-day moving average 369.21

Share statistics

Avg vol (3-month) 34.49M
Avg vol (10-day) 32.95M
Shares outstanding 53.1B
Implied shares outstanding 63.12B
Float 81.54B
% held by insiders 10.00%
% held by institutions 116.87%
Shares short (28 Jun 2024) 46.41M
Short ratio (28 Jun 2024) 41.77
Short % of float (28 Jun 2024) 4N/A
Short % of shares outstanding (28 Jun 2024) 40.21%
Shares short (prior month 31 May 2024) 46.67M

Dividends & splits

Forward annual dividend rate 41.45
Forward annual dividend yield 41.83%
Trailing annual dividend rate 32.90
Trailing annual dividend yield 33.72%
5-year average dividend yield 42.44
Payout ratio 471.60%
Dividend date 325 Mar 2024
Ex-dividend date 422 Feb 2024
Last split factor 22:1
Last split date 327 Jul 2015

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024

Profitability

Profit margin 13.30%
Operating margin (ttm)26.11%

Management effectiveness

Return on assets (ttm)7.04%
Return on equity (ttm)17.29%

Income statement

Revenue (ttm)47.61B
Revenue per share (ttm)2.55
Quarterly revenue growth (yoy)16.50%
Gross profit (ttm)N/A
EBITDA 15.8B
Net income avi to common (ttm)6.33B
Diluted EPS (ttm)2.03
Quarterly earnings growth (yoy)20.90%

Balance sheet

Total cash (mrq)8.02B
Total cash per share (mrq)5.18
Total debt (mrq)34.69B
Total debt/equity (mrq)92.51%
Current ratio (mrq)0.89
Book value per share (mrq)24.17

Cash flow statement

Operating cash flow (ttm)9.7B
Levered free cash flow (ttm)8.68B